glp-1 obesity drug news today september 15 2025 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio 2024 was a record year
Description
Blood pressure should be assessed for consideration of a reduction in the dose of antihypertensives
A synthetic version of one of the peptides found in their venom is used in the painkilling drug ziconotide
As researchers continue to uncover the many roles of GLP-1, GLP-1R, and synthetic GLP-1RAs in systems beyond the endocrine, potential pharmacologic applications of GLP-1RAs in a variety of pathology are becoming increasingly clear
10.1111/dom.15077
NK, RP, SL, and LA wrote the manuscript, and all authors critically revised it
Meisha K
